Skip to main content

Advertisement

Table 1 Expression of c-MET and its correlation with clinicopathological parameters in 121 cases

From: Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma

Parameters Grouping n c-MET [case (%)] χ2test
Positive Negative χ2value P value
Age (year) <60 40 28(70.0) 12(30.0) 0.366 0.562
≥60 81 52(64.2) 29(35.8)   
Gender Male 77 52(67.5) 25(32.5) 1.835 0.168
Female 44 28(63.6) 16(36.4)   
Tumor diameter (cm) <5 48 36(75.0) 12(25.0) 1.108 0.216
≥5 73 44(60.3) 29(39.7)   
Location of tumor Cardia, fundus 20 17(65.0) 3(35.0) 11.239 0.003
Body 37 30(62.2) 7(37.8)   
Pylorus, antrum 64 33(51.6) 31(48.4)   
Lauren classification Intestinal 84 60(71.4) 24(28.6) 0.823 0.132
Diffuse 37 20(54.1) 17(45.9)   
Histological type Grade 1 25 15(40.0) 10(60.0) 0.207 0.839
Grade 2 47 31(66.0) 16(34.0)   
Grade 3 49 34(69.4) 15(30.6)   
Invasion depth T1 18 10(55.6) 8(44.4) 1.928 0.116
T2 32 20(62.5) 12(37.5)   
T3 30 21(70.0) 9(30.0)   
T4 41 29(70.7) 12(29.3)   
Metastatic lymph node ratio <35% 60 33(55.0) 27(45.0) 8.237 0.006
≥35% 61 47(67.0) 14(33.0)   
Involving lymph node station N0 43 22(51.2) 21(48.8) 9.731 0.021
N1 41 30(73.2) 11(26.8)   
N2 26 18(69.2) 8(30.8)   
N3 11 10(90.9) 1(9.1)   
TNM stages Ia 16 9(56.2) 7(43.8) 10.722 0.015
Ib 17 8(47.1) 9(52.9)   
II 20 15(75.0) 5(25.0)   
IIIa 20 14(70.0) 6(30.0)   
IIIb 22 16(72.7) 6(26.3)   
IV 26 18(69.2) 8/(30.8)   
Survival (month) <20 75 57(76.0) 18(24.0) 11.337 0.001
≥20 46 23/(50.0) 23/(50.0)